MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202647113837 A) filed by Telios Pharma, Inc. on September 23, 2026, for Methods And Compositions For Treating Ophthalmic Disease.
Inventor includes Rothbaum, Wayne.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: Therapeutic methods and ophthalmic compositions for reducing ocular mast cell degranulation and/or ocular mast cell cytokine production in a human subject, inhibiting ocular mast cell activation in a human subject, treating dry eye disease (DED) or allergic conjunctivitis (AC) in a human subject, inhibiting mast cell activation in a human subject, and reducing or alleviating a sign or symptom of dry eye disease in a human subject using a BTK inhibitor are described. The disclosure also includes therapeutic methods and ophthalmic compositions for reducing or alleviating a sign or symptom of allergic conjunctivitis in a human subject and treating allergic conjunctivitis in a human subject using a BTK inhibitor.
Disclaimer: Curated by HT Syndication.
